O
DBVT

OrbiMed’s DBV Technologies DBVT Stock Holding History

OrbiMed’s Portfolio DBVT Stock Details DBVT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-66,520
Closed -$14.9M – 137
2018
Q3 		$14.9M Buy
66,520
+25,450
+62% +$5.17M 0.18% 99
2018
Q2 		$7.92M Hold
41,070
– – 0.09% 117
2018
Q1 		$9.47M Sell
41,070
-16,780
-29% -$3.97M 0.12% 106
2017
Q4 		$14.2M Buy
57,850
+6,560
+13% +$1.9M 0.18% 89
2017
Q3 		$21.8M Hold
51,290
– – 0.21% 82
2017
Q2 		$18.3M Hold
51,290
– – 0.19% 81
2017
Q1 		$18.1M Buy
51,290
+16,720
+48% +$5.87M 0.2% 82
2016
Q4 		$12.1M Hold
34,570
– – 0.15% 84
2016
Q3 		$12.6M Buy
+34,570
New +$12M 0.14% 92

Other funds holding DBVT

BBA
Baker Bros. Advisors New York $17.4B AUM 131.5% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
ACH
ArrowMark Colorado Holdings Denver, Colorado $3.76B AUM 21.77% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
FMBTD
First Midwest Bank Trust Division Joliet, Illinois $777M AUM 29.48% 1-Year Est. Return
B
Bpifrance Maisons Alfort, Cedex, France $1.65B AUM 19.85% 1-Year Est. Return
PA
Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

OrbiMed's DBVT Position: Q4 2018 in Review

OrbiMed sold out of DBV Technologies (DBVT) in Q4 2018, closing a stake of 66,520 shares — an estimated $14.9M sold.

OrbiMed first reported a position in DBVT in Q3 2016 and held it in 9 quarters. The position peaked at $21.8M in Q3 2017. 55 funds tracked by Wall St. Rank hold DBVT as of Q4 2018.

  • OrbiMed reported no remaining DBV Technologies position as of Q4 2018 after selling out during the quarter.
  • OrbiMed sold 66,520 DBV Technologies shares in Q4 2018, an estimated $14.9M.
  • OrbiMed first reported a position in DBV Technologies in Q3 2016 and held it in 9 quarters.
  • OrbiMed's DBV Technologies position peaked at $21.8M in Q3 2017.
  • 55 funds tracked by Wall St. Rank held DBV Technologies as of Q4 2018.

Based on OrbiMed's 13F filing for Q4 2018, filed 14 Feb 2019.